M
MDxHealth
Prostate Cancer Diagnostics and Confirmation Tests - MDxHealth
About MDxHealth
Mdxhealth is a commercial stage precision diagnostics company specializing in providing actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The company operates in the healthcare sector, specifically focusing on urologic oncology. Mdxhealth serves healthcare providers, including urologists and oncologists, by offering advanced diagnostic tests that utilize proprietary genetic, epigenetic methylation, and other molecular technologies. These tests assist physicians in making informed decisions regarding the diagnosis and prognosis of prostate cancer, helping to determine the most appropriate course of treatment for patients.
Mdxhealth's business model revolves around the development, validation, and commercialization of its diagnostic tests. The company generates revenue through the sale of these tests to healthcare providers and institutions. By offering precise and personalized diagnostic solutions, Mdxhealth aims to improve patient outcomes and optimize treatment strategies, thereby addressing a critical need in the market for more accurate and individualized cancer diagnostics.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2006
News
Open roles
MDxHealth in the Liège ecosystem
The MDxHealth office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series B and later5 investors entered at this stage
Eurazeo
Biovest International
Petercam
MVM Life Science Partners
Innovatus Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
See MDxHealth on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

